Common European MRSA Originated in Africa

WASHINGTON, DC – August 26, 2014 – The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio®, the online open-access journal of the American Society for Microbiology.

Read more...

New Biomarker Highly Promising for Predicting Breast Cancer Outcomes

WASHINGTON, DC – August 25, 2014 – A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.

Read more...

Highly Drug Resistant, Virulent Strain of Pseudomonas aeruginosa Arises in Ohio

WASHINGTON, DC – August 11, 2014 – A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio. Their investigation suggests that the particular genetic element involved, which is still rare in the United States, has been spreading heretofore unnoticed, and that surveillance is urgently needed. The research is published ahead of print in Antimicrobial Agents and Chemotherapy.

Read more...

Single Enzyme Is Necessary for Development of Diabetes

WASHINGTON, DC – August 14, 2014 – An enzyme called 12-LO promotes the obesity-induced oxidative stress in the pancreatic cells that leads to pre-diabetes, and diabetes. 12-LO’s enzymatic action is the last step in the production of certain small molecules that harm the cell, according to a team from Indiana University School of Medicine, Indianapolis. The findings will enable the development of drugs that can interfere with this enzyme, preventing or even reversing diabetes. The research is published ahead of print in the journal Molecular and Cellular Biology.

Read more...

C. difficile Vaccine Proves Safe, 100 Percent Effective In Animal Models

WASHINGTON, DC – July 31, 2014 – An experimental vaccine protected 100 percent of animal models against the highly infectious and virulent bacterium, Clostridium difficile, which causes an intestinal disease that kills approximately 30,000 Americans annually. The research is published ahead of print in Infection and Immunity.

Read more...

TPL_asm2013_SEARCH